John J. Greisch is corporate vice president and president, international of Baxter International Inc. In this role, he oversees all international, global manufacturing and supply chain operations.
Greisch joined Baxter in 2002 as vice president of finance for Baxter's Renal business. He then assumed the role of vice president of finance and strategy for Baxter's BioScience business before being named president of that business. In 2004, he was named corporate vice president and chief financial officer.
Prior to joining Baxter, Greisch was president and CEO of FleetPride Corporation, after completing an 11-year career at The Interlake Corporation, a diversified global manufacturing company, serving in a variety of roles, including chief financial officer, treasurer, president of Interlake's largest business and president of its European operations based in London.
Greisch is a member of the board of directors of TomoTherapy Incorporated, which develops, markets and sells an advanced radiation therapy system for the treatment of a wide variety of cancers. He is also a director of the Children's Memorial Hospital Foundation Board and a trustee at the John G. Shedd Aquarium.
Greisch received a bachelor's degree in Business Administration from Miami University at Ohio and a master's degree in Management from Northwestern University's J.L. Kellogg Graduate School of Management. He is a certified public accountant and began his business career with PriceWaterhouseCoopers.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
Print this page
